Daniel Ribes

Led innovative projects leveraging the IQVIA Core Obesity Model and integrated Core Obesity-Diabetes Model; coordinated multidisciplinary teams; drove client partnerships to develop and implement health economic models that support better patient outcomes and population health; contributed to the development of integrated disease models for diabetes, obesity and cardiovascular disease using patient-level simulations and peer-reviewed methodologies.

Coordinated HTA submissions for NICE, NCPE, and SMC for clients including Beigene, Pharmanovia, and UCB. Developed a viable decision-making model for NICE submissions and integrated AI solutions to streamline consultancy processes, significantly improving operational efficiency and insights for value-driven healthcare solutions.

Built comprehensive epidemiologic and pharmacoeconomic models for Arexvy (RSV vaccine for older adults). Developed a Dynamic Transmission Cost-Effectiveness Model in Excel, VBA, R, and C++ (collaboration with ICON PLC and RTI). Created Static Cost-Effectiveness and Budget Impact Models for multiple countries (collaboration with CHESS).